Insiders Trades
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Latest filing published 01 Apr 2026 for NEUROONE MEDICAL TECHNOLOGIES Corp, €1,650. Read the official filing
Filing timeline
BuySaleDavid A. Rosa
Insider track record
Disclosed buys
1
Disclosed sells
2
T+90 hit rate
100%
T+90 mean return
+51.5%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
David A. Rosa: trading record in brief
David A. Rosa is a declared insider at 2 companies (chief executive); the most frequent names are NEUROONE MEDICAL TECHNOLOGIES Corp and Biotricity Inc. Over a trading history stretching from 15 September 2021 to 31 March 2026, the count stands at 40 filings.
On the open market, the record shows 1 purchase worth €45k and 2 sales worth €63k. On balance, insiders were net sellers of €18k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 37 share grants.
The record was last updated on 1 April 2026 with a share grant (€1,650) in NEUROONE MEDICAL TECHNOLOGIES Corp. The latest purchase dates back some time: it was published 559 days ago, on 7 April 2025. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David A. Rosa
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations40 total
2,458 shares@ US$0.7770.6% of flowCommon StockSEC:0001540354-26-000005:0
71,325 shares@ US$0.6812.5% of flowCommon StockSEC:0001540354-26-000004:0
2,458 shares@ US$0.7580.5% of flowCommon StockSEC:0001540354-26-000001:0
2,458 shares@ US$0.88860.7% of flowCommon StockSEC:0001540354-25-000009:0
2,458 shares@ US$0.6780.5% of flowCommon StockSEC:0001540354-25-000006:0
100,000 shares@ US$0.5016.1% of flowCommon StockSEC:0001540354-25-000004:0
Canonical exit: 3 Jul 2025 (T+90)
2,458 shares@ US$0.85020.7% of flowCommon StockSEC:0001540354-25-000003:0
71,325 shares@ US$1.1628.1% of flowCommon StockSEC:0001540354-25-000002:0
2,239 shares@ US$1.150.9% of flowCommon StockSEC:0001540354-25-000001:0
4,697 shares@ US$0.8261.3% of flowCommon StockSEC:0001213900-25-000714:0
2,239 shares@ US$0.62310.5% of flowCommon StockSEC:0001540354-24-000013:0
2,239 shares@ US$0.970.7% of flowCommon StockSEC:0001540354-24-000012:0
4,697 shares@ US$0.991.5% of flowCommon StockSEC:0001540354-24-000011:0
2,239 shares@ US$0.79640.6% of flowCommon StockSEC:0001540354-24-000010:0
2,239 shares@ US$0.750.6% of flowCommon StockSEC:0001540354-24-000009:0
4,697 shares@ US$0.801.2% of flowCommon StockSEC:0001540354-24-000008:0
2,239 shares@ US$0.92990.7% of flowCommon StockSEC:0001540354-24-000007:0
2,239 shares@ US$1.130.8% of flowCommon StockSEC:0001540354-24-000006:0
19,673 shares@ US$1.157.6% of flowCommon StockSEC:0001540354-24-000005:0
2,239 shares@ US$1.200.9% of flowCommon StockSEC:0001540354-24-000004:0
2,239 shares@ US$1.210.9% of flowCommon StockSEC:0001540354-24-000003:0
663,497 shares0Common StockSEC:0001540354-24-000002:0
2,239 shares@ US$1.250.9% of flowCommon StockSEC:0001540354-24-000001:0
2,239 shares@ US$1.581.1% of flowCommon StockSEC:0001213900-24-000530:0
2,239 shares@ US$1.451.1% of flowCommon StockSEC:0001540354-23-000013:0
25 of 40 declarations
